| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/27/1997 | US5633283 Method for treating multiple sclerosis |
| 05/27/1997 | US5633282 Inhibition of viral infection |
| 05/27/1997 | US5633280 Urethanes and ureas that induce cytokine production |
| 05/27/1997 | US5633279 5-substituted derivatives of mycophenolic acid |
| 05/27/1997 | US5633277 Antiinflammatory |
| 05/27/1997 | US5633276 Melatonin system disorders |
| 05/27/1997 | US5633275 Photochemotherapeutical obstruction of newly-formed blood vessels |
| 05/27/1997 | US5633274 Treating nonsteroid-hormone dependent cancer with clotrimazole, miconazole or econazole |
| 05/27/1997 | US5633273 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd] indoles |
| 05/27/1997 | US5633270 Thiazolidine derivatives, preparation thereof and drugs containing samem |
| 05/27/1997 | US5633266 Azacyclic compounds compositions containing them and their use as tachykinin antagonists |
| 05/27/1997 | US5633262 Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof |
| 05/27/1997 | US5633261 Immunostimulating swainsonine analogs |
| 05/27/1997 | US5633260 11,7 Substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof |
| 05/27/1997 | US5633259 Method for identification of low/non-addictive opioid analgesics and the use of said analgesics for treatment of opioid addiction |
| 05/27/1997 | US5633257 Phosphodiesterase inhibitor |
| 05/27/1997 | US5633255 1,2-dihydro-2-oxo-3-aminoquinoxaline derivatives, their preparation and their therapeutic application |
| 05/27/1997 | US5633253 Substituted thiosemicarbazonic acid esters |
| 05/27/1997 | US5633251 N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 05/27/1997 | US5633246 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/27/1997 | US5633245 Inhibition of expression of beta-lactamase using esters of fatty acid alcohols |
| 05/27/1997 | US5633244 Histamine-h2 antagonists |
| 05/27/1997 | US5633242 Pharmaceuticals for contraception/hormone substitution containing a biogenous estrogen component |
| 05/27/1997 | US5633241 Administering as antileukemia agent |
| 05/27/1997 | US5633240 Parenteral solutions containing metolazone |
| 05/27/1997 | US5633239 Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them |
| 05/27/1997 | US5633238 Method for the treatment of schizophrenia |
| 05/27/1997 | US5633235 Triciribine and analogs as antiviral drugs |
| 05/27/1997 | US5633228 Prevention and treatment of peripheral neuropathy |
| 05/27/1997 | US5633226 Water in oil emulsion with water solubility active ingredient, triglyceride or diester of propylene glycol, surfactant and additive capable of converting mixture to oil in water emulsion by addition of water |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/27/1997 | US5633016 Administering cisplatin and topotecan synergistic mixture as antitumor agents |
| 05/27/1997 | US5633015 Drug dosage units |
| 05/27/1997 | US5633014 Solid, non-porous microspheres of injectable analgesic and adjuvant that decreases the melting point of the analgesic obtained by spraying mixture in melted state to form droplets and rapidly freezing droplets |
| 05/27/1997 | US5633011 Progesterone replacement therapy |
| 05/27/1997 | US5633009 Transdermal administration of azapirones |
| 05/27/1997 | US5633008 Method of administering nicotine transdermally |
| 05/27/1997 | US5633006 Oxide of a group 2a metal |
| 05/27/1997 | US5633005 Dimeticon pastilles |
| 05/27/1997 | US5633003 Use of intratracheally administered hyaluronic acid to ameliorate emphysema |
| 05/27/1997 | US5633000 Subcutaneous implant |
| 05/27/1997 | US5632997 Method of treating liver disfunction in mammals, using active principle isolated from shark tissue |
| 05/27/1997 | US5632996 Non-irritating |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | US5632980 AIDS therapeutic agents comprising polymers formed from cinnamic acid derivatives |
| 05/27/1997 | US5632979 Method and composition for preventing surgical adhesions |
| 05/27/1997 | US5632972 Using mixture of zinc salt, peroxy compound and a bicarbonate salt |
| 05/27/1997 | US5632970 Fluoresence detection using texaphyrins |
| 05/27/1997 | US5632897 Dialysis, complexing |
| 05/27/1997 | CA2131185C Substituted pipecolinic acid derivatives as hiv protease inhibitors |
| 05/27/1997 | CA2119777C An ameliorant for blood lipid metabolism |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/24/1997 | CA2190801A1 Leukotriene antagonistic benzoic acid derivatives |
| 05/23/1997 | CA2190700A1 Crystalline hydrochloride of (r)-(-)-2 n-[4-(1,1-dioxido-3-oxo-2, 3-dihydrobenzisothiazol-2-yl)-butyl]-aminomethyl-chroman |
| 05/22/1997 | WO1997018332A1 Regulation of cancer-causing tyrosine kinases by potassium ion conductance |
| 05/22/1997 | WO1997018320A1 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids |
| 05/22/1997 | WO1997018317A1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 05/22/1997 | WO1997018312A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | WO1997018307A1 Fas ligand fusion protein |
| 05/22/1997 | WO1997018304A1 Methods for modulation of cholesterol transport |
| 05/22/1997 | WO1997018303A1 Rac-proteine kinase as therapeutic agent or in diagnostics |
| 05/22/1997 | WO1997018300A2 Murine model for human carcinoma |
| 05/22/1997 | WO1997018245A1 Complex of naproxen and beta-cyclodextrin |
| 05/22/1997 | WO1997018241A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | WO1997018239A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 05/22/1997 | WO1997018237A1 Chemokine from niddm pancreas |
| 05/22/1997 | WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r) |
| 05/22/1997 | WO1997018229A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | WO1997018223A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | WO1997018220A1 A heterocyclic chemical compound |
| 05/22/1997 | WO1997018216A1 Production of a salt of clavulanic acid |
| 05/22/1997 | WO1997018215A1 Analogues of n-acetylardeemin, method of preparation and uses thereof |
| 05/22/1997 | WO1997018214A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997018213A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997018212A1 Aryl and heteroaryl purine compounds |
| 05/22/1997 | WO1997018210A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997018208A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/22/1997 | WO1997018207A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 05/22/1997 | WO1997018206A1 Morpholine derivatives and their use as therapeutic agents |
| 05/22/1997 | WO1997018205A1 Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/22/1997 | WO1997018194A1 CYCLIC AND HETEROCYCLIC N-SUBSTITUTED α-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS |
| 05/22/1997 | WO1997018193A1 Antimalarial quinolin derivatives |
| 05/22/1997 | WO1997018192A1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 05/22/1997 | WO1997018191A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 05/22/1997 | WO1997018188A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 05/22/1997 | WO1997018185A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 05/22/1997 | WO1997018184A1 Fluorinated propranolol and related methods |
| 05/22/1997 | WO1997017993A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 05/22/1997 | WO1997017992A1 Improved formulation for administration of steroid compounds |
| 05/22/1997 | WO1997017990A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 05/22/1997 | WO1997017989A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 05/22/1997 | WO1997017985A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017983A1 Methods of treating disorders of non-visual sensory epithelia |
| 05/22/1997 | WO1997017981A1 Anti-viral isolates obtainable from leeches |
| 05/22/1997 | WO1997017978A1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 05/22/1997 | WO1997017977A1 Topical compositions containing a beta-cyclodextrin and an amino polysaccharide |
| 05/22/1997 | WO1997017976A1 Microcellulose-based preparations |
| 05/22/1997 | WO1997017975A1 A glibenclamide-metformin combination for the treatment of diabetes mellitus of type ii |
| 05/22/1997 | WO1997017973A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017971A1 Use of epinastine in the treatment of pain |